PortViewPortView
Albany Molecular Research logo

Albany Molecular Research (AMRI) Stock Analysis

NASDAQHealthcareBiotechnology

$21.74+0.00%
52-week range$21.74
$13.01$22.17

What Albany Molecular Research does

Albany Molecular Research, Inc. (NASDAQ: AMRI) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
0.00
Beta
1.04
Dividend yield
0.00%
Revenue / share
$13.44
50-day avg
$21.71
200-day avg
$18.29
52-week high
$22.17
52-week low
$13.01

ETFs linked to AMRI

Broad-market and Healthcare sector ETFs an investor holding Albany Molecular Research is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AMRI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AMRI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Albany Molecular Research?
Albany Molecular Research trades under the ticker AMRI on NASDAQ.
Which exchange is AMRI listed on?
AMRI is listed on NASDAQ.
What sector does Albany Molecular Research operate in?
Albany Molecular Research is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AMRI in a portfolio?
PortView shows AMRI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.